Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-11-21

FDA Approved: HYDROCORTISONE BUTYRATE — Original Application (The J. Molner Company LLC)

View source ↗

Summary

The FDA approved a generic topical hydrocortisone butyrate product under an Original Application (ANDA 209556) from The J. Molner Company LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydrocortisone Butyrate (hydrocortisone butyrate)

Snippet

ORIG AP for HYDROCORTISONE BUTYRATE (HYDROCORTISONE BUTYRATE)